skip to content »

Neurology

Houston, Texas

The Cullen Building at Baylor College of Medicine.
Department of Neurology
not shown on screen

Poster and Platform Presentations by Neurology Residents

Click on the Expand plus sign sign to list the poster and platform presentations by year. Then click on the link to view that presentation.

Time Line

Expand All

2014

Collapse All | Expand All

 

    American Academy of Neurology (AAN)
    66th Annual Meeting in Philadelphia, Penn. (April 26 - May 3, 2014)

    • New risk score improves vasospasm prediction following subarachnoid hemorrhage using markers of vascular compliance.

      Anand A, Hussein H, Ezzeddine M, Kass J, Suarez J

    • Optical coherence tomography visualization of optic nerve head structure detects acute changes in the intracranial pressure.

      Anand A, Pass A, Calvillo E, Tang R, Cajavilca C, Urfy M, et al.

    • Cardiac valve strands in ischemic stroke: Strand effects and outcomes of medical or surgical intervention.

      Chu J, Fabian R

    • Myelitis following intrathecal chemotherapy in acute lymphoblastic leukemia: A case report.

      Parker A, Yassin A, Woodman K

    • Reversible dementia with myoclonus due to concurrent HSV-2 and syphilis central nervous system infection in an immunocompetent man.

      Robles L, Anand A, Kass J

    • Delayed diagnosis of brachial plexus neurolymphomatosis in post-transplant patient with diffuse large b-cell lymphoma.

      Stosic M, Tummala S

    • Resource utilization in patients with suspected psychogenic non epileptic seizures and drug resistant epilepsy in the Harris County Health District between 2009 and 2012.

      Wolf B, Hayashi B, Sachs E, Van Hook C, Murphey D, Goldsmith C

2013

Collapse All | Expand All

 

2012

Collapse All | Expand All

 

<2011

Collapse All | Expand All

 

    Association for Research in Vision and Ophthalmology (ARVO)
    2011 Annual Meeting in Fort Lauderdale, Fla. (May 1-5, 2011)

    • Analysis of corneal biomechanical properties in patients with exfoliation syndrome and exfoliative glaucoma.

      Prata TS, De Moraes GV, Anand A, Tello C, Liebmann JM, Ritch R

    • Use of amniotic membrane graft in glaucoma shunt surgery.

      Sheha H, Anand A, Tello C

    American Academy of Neurology (AAN)
    63rd Annual Meeting in Honolulu, Hawaii (April 9-16, 2011)

    • Contemporary management of intracranial and extracranial large vessel disease.
      [Educational Program]

      Alenzi B, Feldmann E

    • Distal limb discoloration in patients with multiple sclerosis - Case series of 41 patients.

      Avila M, Prieto P, Avila-Ornelas J, Stosic M, Amin A, Hutton GJ, et al.

    • Rates of acute stroke intervention following inter-county air transfer: a study on patients from the Florida Keys.

      Kottapally M, Shang T, Wolf B, Brotons A, Romano JG, Yavagal DR

    Consortium of Multiple Sclerosis Centers (CMSC)
    24th Annual Meeting in San Antonio, Texas (June 2-5, 2010)

    Association for Research in Vision and Ophthalmology (ARVO)
    2010 Annual Meeting in Fort Lauderdale, Fla. (May 2-6, 2010)

    • Short-duration visual evoked potential as an objective tool for screening refractive errors.

      Anand A, De Moraes CG, Teng CC, Liebmann JM, Ritch R, Tello C

    American Academy of Neurology (AAN)
    62nd Annual Meeting in Toronto, Canada (April 10-17, 2010)

    American Glaucoma Society (AGS)
    20th Annual Meeting in Naples, Fla. (March 4-7, 2010)

    • Corneal hysteresis and visual field asymmetry in open angle glaucoma.

      Anand A, De Moraes CG, Teng CC, Tello C, Liebmann JM, Ritch R

    Southern Medical Association (SMA)
    Annual Scientific Assembly in Nashville, Tenn. (Dec. 3-5, 2009)

    • Urinoma - A rare complication of prostatic carcinoma.

      Negi S, Anand A, Spannuth C

    Society for Neuroscience (SFN)
    39th Annual Meeting in Chicago, Ill. (Oct. 17-21, 2009)

    University of Texas School of Public Health
    Alzheimers and Dementia Research Symposium in Houston, Texas (June 17, 2009)

    Consortium of Multiple Sclerosis Centers (CMSC)
    23rd Annual Meeting in Atlanta, Ga. (May 27-30, 2009)

    Association for Research in Vision and Ophthalmology (ARVO)
    2009 Annual Meeting in Fort Lauderdale, Fla. (May 3-7, 2009)

    • Outcome of sequential glaucoma implants in refractory glaucoma.

      Anand A, Tello C, Sidoti PA, Ritch R, Liebmann JM

    American Academy of Neurology (AAN)
    61st Annual Meeting in Seattle, Wash. (April 25 - May 2, 2009)

    World Congress on Treatment and Research in Multiple Sclerosis (ACTRIMS + ECTRIMS + LACTRIMS)
    Montreal, Quebec, Canada (Sept. 17-20, 2008)

    • Natalizumab use in a large multiple sclerosis center: Ascertaining the therapeutic benefit and the causes for treatment discontinuation.

      Batra N, Ramanathan M, Hojnacki D, Miller C, Umhauer M, Stosic M, et al.

    • 3T predicts better clinical and demographic outcomes in patients with multiple sclerosis than 1.5T. A preliminary case-control study.

      Di Perri C, Dwyer M, Cox JL, Hashmi K, Wack D, Hussein S, et al.

    • Lesion characteristics at 1.5 and 3 Tesla in multiple sclerosis patients and healthy controls: A morphological and topological quantitative comparison study.

      Di Perri C, Dwyer M, Wack D, Cox JL, Hashmi K, Saluste E, et al.

    • ApoE ε4 positive multiple sclerosis patients develop more gray matter and whole brain atrophy: A 4-year longitudinal study using the 15-year disease onset model.

      Horakova D, Kyr M, Havrdova E, Dolezal O, Seidl Z, Vaneckova M, et al.

    • Can magnetization transfer data from different magnetic resonance imaging scanner/sequence/pulse types be standardized? An application of correction factor function method.

      Kelemen A, Dwyer MG, Hussein S, Stosic M, Liang Y, Zivadinov R

    • Conventional and non-conventional quantitative magnetic resonance imaging outcomes differ when comparing multiple definitions of benign multiple sclerosis.

      Passanese J, Kelemen A, Weinstock-Guttman B, Teter B, Mihai C, Hojnacki D, et al.

    • Protective clinical, demographic and conventional and non-conventional magnetic resonance imaging predictors of benign multiple sclerosis: A large cohort study.

      Passanese J, Kelemen A, Weinstock-Guttman B, Teter B, Mihai C, Hojnacki D, et al.

    • Does multiple sclerosis become an ischemic disease over time? A 3-year follow-up study of patients positive for the presence of anti-phospholipid antibodies.

      Stosic M, Weinstock-Guttman B, Vutla B, Ambrus J, Ramanathan M, Munschauer F, et al.

    American Academy of Neurology (AAN)
    60th Annual Meeting in Chicago, Ill. (April 12-19, 2008)

    • Gender related differences in multiple sclerosis. A large cohort study of conventional and non-conventional MRI measures.

      Antulov R, Weinstock-Guttman B, Cox JL, Hussein S, Durfee J, Dwyer MG, et al.

    • Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic and demyelinating lesions.

      Bergsland N, Dwyer M, Stosic M, Sharma J, Nussenbaum F, Durfee J, et al.

    • Cigarette smoking accelerates the evolution of brain atrophy and influences the severity of blood-brain-barrier disruption in multiple sclerosis.

      Durfee J, Weinstock-Guttman B, Stosic M, Abdelrahman N, Teter B, Munschauer F, et al.

    • A voxel-wise random field theory-based magnetization transfer approach for detecting focal demyelination and remyelination in multiple sclerosis.

      Dwyer MG, Stosic M, Hussein S, Keleman A, Wack D, Zivadinov R

    • Presence of concomitant Th1-mediated concomitant diseases predicts more severe MRI outcome on non-conventional MRI measures in patients with multiple sclerosis.

      Raj B, Weinstock-Guttman B, Teter B, Stosic M, Cox JL, Hussein S, et al.

    • Lower gray matter and higher lesion volumes differentiate patients with primary antiphospholipid syndrome and multiple sclerosis.

      Stosic M, Ambrus J, Garg N, Weinstock-Guttman B, Ramanathan M, Munschauer FE, et al.

    • Gray matter atrophy and destruction of T1 lesions are more frequent in familial cases with multiple sclerosis, and especially in those with first degree relatives.

      Stosic M, Weinstock-Guttman B, Munschauer FE, Abdelrahman N, Hussein S, Ramanathan M, et al.

    • Multiple sclerosis patients with presence of anti-phospholipid antibodies develop more severe brain damage over 3 years.

      Zivadinov R, Stosic M, Vulta N, Ambrus J, Ramanathan M, Munschauer F, et al.

    American College of Physicians (ACP)
    Tennessee Chapter Scientific Meeting in Chattanoogan, Tenn. (Oct. 12-13, 2007)

    • Doctor - A case of benign thyroid cyst causing reversible Horner's syndrome.

      Negi S, Anand A

    European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    23rd Congress in Prague, Czech Republic (Oct. 11-14, 2007)

    • Extent of subcortical and cortical atrophy and disease severity in patients with multiple sclerosis.

      Ramasamy DP, Benedict RHB, Dwyer MG, Stosic M, Fritz D, Zivadinov R

    • Non-conventional MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.

      Stosic M, Ambrus J, Garg N, Weinstock-Guttman B, Ramanathan M, Munschauer FE, et al.

    • Conventional and non-conventional MRI characteristics of familial and sporadic multiple sclerosis.

      Zivadinov R, Munschauer FE, Abdelrahman N, Hussein S, Ramanathan M, Durfee J, et al.

    • Cigarette smoking and MRI characteristics in multiple sclerosis.

      Zivadinov R, Stosic M, Abdelrahman N, Teter BE, Munschauer FE, Hussein S, et al.

    Federation of Clinical Immunology Societies (FOCIS)
    7th Annual Meeting in San Diego, Calif. (June 7-11, 2007)

    • HIV-1 infectivity inhibited by binding of the green tea catechin, epigallocatechin gallate, to CD4.

      Nance C, Siwack E, Ram A, Willis V, Westerfield S, Shearer W

    12th International Congress on Infectious Diseases (ICID)
    Lisbon, Portugal (June 15-18, 2006)

    • Seroepidemiology of Crimean-Congo haemorrhagic fever among butchers and slaughters of the Isfahan province, Iran in 2005.

      Karimi I, Rostami M, Chinikar S, Ataei B, Darvishi M, Jalali N, et al.

    Federation of Clinical Immunology Societies (FOCIS)
    6th Annual Meeting in San Francisco, Calif. (June 1-5, 2006)

    • HIV-1-GP120-induced T-cell responses attenuated by the green tea catechin, epigallocatechin gallate (EGCG).

      Nance C, Ram A, Paulson S, Shearer W

    Mashad University of Medical Sciences
    Seminars in Infectious Diseases (2006)

    • Efficacy of tetracycline versus azithromycin in combination with bismuth, metronidazole, and proton pump inhibitor for treatment of Helicobacter pylori infection.

      Jalali N, Karimi I

    Leiden International Medical Student Congress (LIMSC)
    2nd Annual Meeting in Leiden, The Netherlands (April 7-9, 2005)

    • Significance of coronary disease among patients with diabetes.

      Stosic M, Igic M

    15th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID)
    Copenhagen, Denmark (April 2-5, 2005)

    • Seroepidemiology of Crimean-Congo hemorrhagic fever in local and imported sheep in Isfahan province, Iran in 2002.

      Darvishi M, Ataee B, Chinikar S, Jalali N, Mardani M, Mirkhani M

    International Medical Sciences Student Congress (IMSSC)
    19th Annual Meeting in Istanbul, Turkey (May 6-9, 2004)

    • Traditional education modalities of present anatomy curriculum in Belgrade Medical School.

      Stosic M, Tomic A, Kresojevic N, Milenkovic P, Popovic D

    Isfahan University of Medical Sciences
    Seminars in Infectious Diseases (2004)

    • Effectiveness of one week of parenteral plus three weeks of oral antibiotic treatment in patients with resistant chronic sinusitis.

      Jalali N, Karimi I

    Mashad University of Medical Sciences
    (Dissertation) (1999)

    • Prospective study of electromyographic and electroneurographic changes in peripheral motor and sensory nerves in patients with organophosphate poisoning.

      Jalali N, Balali-Mood M

E-mail this page to a friend